Search Within

Richard Jirui Lin

  1. "Harper Hubbeling"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (4)
Groups
  1. Bone Marrow Transplant (13)
  2. CTCR Scholars (13)
  3. Center for Hematologic Malignancies (13)
  4. Department of Medicine (13)
  5. GME, Radiation Oncology (13)
  6. Graduate Medical Education (13)

More Groups

People
  1. Ana Alarcon Tomas (13)
  2. Brandon Imber (13)
  3. Gunjan Shah (13)
  4. Harper Hubbeling (13)
  5. Maria Palomba (13)
  6. Michael Scordo (13)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (2)
  4. 2021 (2)
Publications
  1. Blood (5)
  2. Hematological Oncology (2)
  3. Transplantation and Cellular Therapy (2)
  4. Blood Advances (1)
  5. Clinical Cancer Research (1)
  6. International Journal of Radiation Oncology, Biology, Physics (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Elsevier Inc. (3)
  3. Wiley Blackwell (2)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save